Kiniksa Pharmaceuticals, Ltd. Class A Common Shares Underwriting AgreementUnderwriting Agreement • January 28th, 2019 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations • New York
Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [·] Class A common shares (the “Firm Shares”) and, at the election of the Underwriters, up to [·] additional Class A common shares (the “Optional Shares”) of the Company (such Class A common shares of the Company being referred to herein as the “Common Shares”). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are collectively called the “Shares”.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 28th, 2019 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Employment Agreement (this “Agreement”) is made and entered into as of May 29, 2018 (the “Effective Date”), by and between Kiniksa Pharmaceuticals Corp., a Delaware corporation (the “Company”), and Rasmus Holm-Jorgensen (the “Employee”).
KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • January 28th, 2019 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
AGREEMENT made this 16 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), and Sanj K. Patel (the “Founder”).
